HCW Biologics Raises $4 Million Through Private Placement of Unregistered Warrants
I'm PortAI, I can summarize articles.
HCW Biologics Inc. has raised approximately $4 million through a warrant inducement agreement with an investor, amending the exercise price to $2.66 per share for 1,510,205 shares. Additionally, unregistered warrants for 3,020,410 shares at $2.41 per share will be issued in a private placement. Maxim Group LLC is the exclusive financial advisor, with closing expected around November 20, 2025. The company plans to file a registration statement for the resale of shares from the new warrants.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments